General Practice · Saint Augustine, FL
NPI
1023384179
Since 2012
Specialty
General Practice
Code 208D00000X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
16 Saint Johns Medical Park Dr
Saint Augustine, FL, 32086
Phone (904) 794-5411
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
2,580 services
Medicare patients, 2024
331
Average age 72
Drug cost, 2024
$817K
9,242 prescriptions
Company payments, 2025
$956
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajesh A Persaud was code 99214 (office e&m - established), 969 times for 299 patients. In total Rajesh A Persaud billed 2,580 services in 38 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 969 | 299 | $83.83 | $81K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 580 | 11 | $0.11 | $60.95 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 123 | 123 | $17.88 | $2,199 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 103 | 13 | $0.33 | $34.11 |
| 96372 Injection Administration | Office | 80 | 32 | $10.21 | $817 |
| 99213 Office E&M - Established | Office | 67 | 58 | $57.91 | $3,880 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 64 | 13 | $0.44 | $27.98 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 57 | 52 | $12.77 | $728 |
| 87811 Immunoassay | Office | 51 | 47 | $40.55 | $2,068 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 45 | 45 | $125.05 | $5,627 |
| 81003 Clinical Chemistry | Office | 36 | 25 | $2.20 | $79.2 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 32 | 28 | $213.41 | $6,829 |
| 99204 Office E&M - New | Office | 23 | 23 | $76.89 | $1,768 |
| 99497 Care Management/Coordination | Office | 17 | 17 | $45.56 | $775 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 14 | 13 | $146.85 | $2,056 |
By year: 2022 $127K for 1,942 services; 2023 $106K for 1,714 services; 2024 $110K for 2,580 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87811 Immunoassay | 51 | 47 | $40.55 | $2,068 |
| 81003 Clinical Chemistry | 36 | 25 | $2.20 | $79.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Rajesh A Persaud prescribed most often to Medicare patients was Levothyroxine Sodium, with 329 prescriptions and refills. In total Rajesh A Persaud wrote 9,242 Medicare prescriptions that cost $817K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 329 | 855 | 96 | $4,483 |
| Atorvastatin Calcium Generic | 278 | 734 | 91 | $2,555 |
| Lisinopril Generic | 227 | 571 | 74 | $1,696 |
| Rosuvastatin Calcium Generic | 214 | 568 | 66 | $2,199 |
| Losartan Potassium Generic | 203 | 574 | 73 | $1,513 |
| Amlodipine Besylate Generic | 182 | 506 | 70 | $1,026 |
| Metformin Hcl Generic | 161 | 432 | 54 | $980 |
| Omeprazole Generic | 142 | 336 | 42 | $2,773 |
| Montelukast Sodium Generic | 141 | 311 | 57 | $1,259 |
| Gabapentin Generic | 130 | 338 | 60 | $2,796 |
| Azithromycin Generic | 122 | 122 | 99 | $437 |
| Pantoprazole Sodium Generic | 119 | 283 | 44 | $1,030 |
| Potassium Chloride Generic | 118 | 292 | 37 | $1,305 |
| Prednisone Generic | 111 | 167 | 84 | $325 |
| Metoprolol Tartrate Generic | 109 | 270 | 31 | $621 |
Brand drugs: 1,059 claims; generic drugs: 8,127 claims; opioid claims: 246.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajesh A Persaud $956 ($956 in general payments such as food, travel and fees) from 19 companies. The largest payer was Novo Nordisk Inc with $257.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 4 | $257 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $109 |
| Insmed, Inc. INSM | 4 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $62.29 |
| Lilly USA, LLC LLY | 3 | $56.39 |
| Exact Sciences Corporation EXAS | 3 | $45.55 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $44.63 |
| Renalytix AI, Inc. | 2 | $42.74 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $33.17 |
| Biogen, Inc. BIIB | 1 | $26.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.